Free Trial

Algert Global LLC Buys 49,230 Shares of Proto Labs, Inc. $PRLB

Proto Labs logo with Industrials background

Key Points

  • Algert Global LLC increased its ownership in Proto Labs, Inc. by 137.3% during the first quarter, bringing their total shares to 85,084 with a value of $2.98 million.
  • Proto Labs reported earnings of $0.41 EPS in its latest quarter, exceeding analyst expectations of $0.33 EPS, with revenue up 7.6% year-over-year to $135.06 million.
  • Analysts have raised ratings on Proto Labs, with Craig Hallum and Cantor Fitzgerald both issuing "buy" ratings and price targets of $54.00 and $51.00, respectively.
  • Need better tools to track Proto Labs? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Algert Global LLC raised its holdings in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) by 137.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 85,084 shares of the industrial products company's stock after acquiring an additional 49,230 shares during the quarter. Algert Global LLC owned approximately 0.36% of Proto Labs worth $2,981,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Sterling Capital Management LLC increased its holdings in Proto Labs by 764.1% during the fourth quarter. Sterling Capital Management LLC now owns 795 shares of the industrial products company's stock worth $31,000 after buying an additional 703 shares during the last quarter. GAMMA Investing LLC increased its holdings in Proto Labs by 249.4% during the first quarter. GAMMA Investing LLC now owns 926 shares of the industrial products company's stock worth $32,000 after buying an additional 661 shares during the last quarter. Quarry LP increased its holdings in Proto Labs by 175.7% during the fourth quarter. Quarry LP now owns 1,585 shares of the industrial products company's stock worth $62,000 after buying an additional 1,010 shares during the last quarter. CWM LLC increased its holdings in Proto Labs by 50.4% during the first quarter. CWM LLC now owns 1,840 shares of the industrial products company's stock worth $64,000 after buying an additional 617 shares during the last quarter. Finally, PNC Financial Services Group Inc. increased its holdings in Proto Labs by 14.1% during the first quarter. PNC Financial Services Group Inc. now owns 2,165 shares of the industrial products company's stock worth $76,000 after buying an additional 267 shares during the last quarter. 84.54% of the stock is owned by institutional investors.

Insider Transactions at Proto Labs

In other Proto Labs news, CEO Suresh Krishna bought 1,725 shares of the firm's stock in a transaction on Monday, August 4th. The shares were purchased at an average price of $43.51 per share, for a total transaction of $75,054.75. Following the completion of the transaction, the chief executive officer directly owned 18,021 shares in the company, valued at approximately $784,093.71. The trade was a 10.59% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. 1.20% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Proto Labs from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 2nd. Cantor Fitzgerald boosted their target price on shares of Proto Labs from $50.00 to $51.00 and gave the stock an "overweight" rating in a report on Friday, August 1st. Finally, Craig Hallum raised shares of Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 price objective for the company in a research report on Friday, August 1st. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $52.50.

Get Our Latest Research Report on Proto Labs

Proto Labs Price Performance

PRLB stock traded down $0.01 during midday trading on Monday, reaching $50.68. The company had a trading volume of 82,811 shares, compared to its average volume of 211,879. The company has a market capitalization of $1.21 billion, a price-to-earnings ratio of 84.49 and a beta of 1.33. The stock has a 50 day moving average price of $42.07 and a 200-day moving average price of $39.22. Proto Labs, Inc. has a 1-year low of $26.34 and a 1-year high of $51.09.

Proto Labs (NYSE:PRLB - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The industrial products company reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.08. The business had revenue of $135.06 million during the quarter, compared to the consensus estimate of $128.05 million. Proto Labs had a return on equity of 2.22% and a net margin of 2.91%.Proto Labs's revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.38 earnings per share. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. As a group, research analysts anticipate that Proto Labs, Inc. will post 0.81 earnings per share for the current year.

Proto Labs Company Profile

(Free Report)

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.

Featured Stories

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Should You Invest $1,000 in Proto Labs Right Now?

Before you consider Proto Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.

While Proto Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market
Next Tech Boom: AI Robots Are Coming Sooner Than You Think!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines